Alzheimer's dementia
Beschreibung
Abnormal processing of amyloid precursor protein (APP) and accumulation of amyloid beta peptides is a hallmark of Alzheimer's dementia. The protease ADAM10 cleaves APP in a neuroprotective manner and thus prevents the accumulation of amyloid beta peptides. Our goal is to develop molecules that increase ADAM10 activity for the treatment of Alzheimer's dementia.
Eckdaten
Projektleitung
Projektteam
Projektpartner
Universitätsspital Basel
Projektstatus
Start bevorstehend, 01/2025
Institut/Zentrum
Institut für Chemie und Biotechnologie (ICBT)
Drittmittelgeber
Innosuisse-Innovationsprojekt / Projekt Nr. 119.341